The U.S. government is close to a deal with Pfizer for up to an additional 100 million doses of its coronavirus vaccine, sources told CNBC’s Meg Tirrell on Tuesday.
The deal could be announced as early as Wednesday, according to a source. The New York Times first reported the news.
Pfizer declined to comment, saying the company “is not able to comment on any confidential discussions that may be taking place with the U.S. government.” The U.S. Department of Health and Human Services did not immediately respond to a request for comment.
